Floatz logo

Dexmedetomidine

Osteoarthritis, Knee

Poznan University of Medical SciencesSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

30 Active assets in the Osteoarthritis, Knee cohort.

Asset / SponsorPhaseRating
Duloxetine
Orthopaedic Arthroscopy Knee and Shoulder Clinic
Phase 4BBB
Naproxen
Pfizer
Phase 3BB
DEXTROSE SOLUTION
Kastamonu University
Phase 4BB
Oxycodone
Riku Antero Palanne
Phase 3BB
Celecoxib
Pfizer
Phase 4BB

View all 48 →

Same molecule, other indications

Dexmedetomidine is also rated in:

schizophreniform disorderActive
A
Indicative · Phase 4
80 / 100
View asset →
schizoaffective disorderActive
BBB
Indicative · Phase 4
77 / 100
View asset →
neuralgiaActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →